9 Meters Biopharma, Inc. Stock Insider Trading

NASDAQ Stock Exchange > Healthcare > Biotechnology

$0.0722

+0 (+0%)

At Close: Nov 20, 2023

9 Meters Biopharma, Inc. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 39.20. In total, the insiders bought 5 838 482 929 and sold 18 657 625 NMTR shares in the last 100 trades.

Insider Power (Last 100 transactions)	39.20
Buy	58 384 829 Shares
Sell	18 657 625 Shares

Historical Insider Trades

Date	Type	Action	Person	Amount
Apr 21, 2023	Common stock	Sell	Sensenig Bethany	9 100
Mar 29, 2023	Common Stock	Buy	Sirgo Mark A	7 885
Mar 29, 2023	Common Stock	Buy	Rice Yehuda Michael	7 885
Mar 29, 2023	Common Stock	Buy	Johnson Lorin K	7 885
Mar 29, 2023	Common Stock	Buy	Constantino Michael T.	7 885
Mar 29, 2023	Common Stock	Buy	Ventimiglia Samantha	7 885
Mar 27, 2023	Common Stock	Buy	Sensenig Bethany	50 177
Mar 27, 2023	Common Stock	Buy	Temperato John	68 815
Jul 06, 2022	Common stock	Buy	Temperato John	125 000
Jul 01, 2022	Common stock	Buy	Sirgo Mark A	175 000
Jul 01, 2022	Common stock	Buy	Sirgo Mark A	175 000
Jun 22, 2022	Stock Option (Right to Buy)	Buy	Sirgo Mark A	142 509
Jun 22, 2022	Stock Option (Right to Buy)	Buy	Sirgo Mark A	142 509
Jun 22, 2022	Stock Option (Right to Buy)	Buy	Ventimiglia Samantha	142 509
Jun 22, 2022	Stock Option (Right to Buy)	Buy	Rice Yehuda Michael	142 509
Jun 22, 2022	Stock Option (Right to Buy)	Buy	Rice Yehuda Michael	142 509
Jun 22, 2022	Stock Option (Right to Buy)	Buy	Johnson Lorin K	142 509
Jun 22, 2022	Stock Option (Right to Buy)	Buy	Johnson Lorin K	142 509
Jun 22, 2022	Stock Option (Right to Buy)	Buy	Constantino Michael T.	142 509
May 23, 2022	Common Stock	Buy	Constantino Michael T.	16 000
May 18, 2022	Common Stock	Buy	Temperato John	50 000
May 18, 2022	Common Stock	Buy	Sirgo Mark A	106 383
Mar 03, 2022	Common stock	Buy	Sirgo Mark A	86 450
Mar 03, 2022	Common stock	Buy	Temperato John	100 000
Feb 21, 2022	Stock Option (Right to Buy)	Buy	Temperato John	2 479 060

About 9 Meters Biopharma, Inc.

9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial for treatment of multi-system inflammatory syndrome; and Vurolenatide... NMTR Profile

Golden Star

Ticker	Date	Change	Price
ANGL	Jun 20	0.0350%	$28.57
BRK-A	Jun 20	0.575%	$617,249.90
EPD	Jun 18	2.90%	$28.30
USFD	Jun 18	4.33%	$53.14
UFPT	Jun 18	2.69%	$253.79
^DJI	Jun 18	1.48%	38,834.86 points
SARK	Jun 17	2.34%	$30.34
RGA	Jun 17	1.53%	$203.90
MA	Jun 17	1.68%	$448.11
BR	Jun 17	1.44%	$197.65

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In